NCT06789198 2026-02-12
FusionVAC22_02
University Hospital Tuebingen
Phase 1 Recruiting
Clinical Trials
3 trialsNCT04248569 2025-12-03
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Recruiting
NCT05937295 2024-12-09
FusionVAC22
University Hospital Tuebingen
Phase 1 Recruiting